標(biāo)題: SCIE期刊DRUGS IN R&D 2024/2025影響因子:2.237 (DRUGS R&D) (1174-5886). (PHARMACOLOGY & PHARMACY)(藥理學(xué)與藥學(xué))Science Citation Index [打印本頁(yè)] 作者: 近地點(diǎn) 時(shí)間: 2025-3-21 17:51
SCIE(SCI)期刊DRUGS IN R&D(20 21 REV HIST)影響因子
SCIE(SCI)期刊DRUGS IN R&D(DRUGS R&D)影響因子@(藥理學(xué)與藥學(xué))學(xué)科排名
SCIE(SCI)期刊DRUGS IN R&D(20 21 REV HIST)總引論文
SCIE(SCI)期刊DRUGS IN R&D(DRUGS R&D)總引論文@(藥理學(xué)與藥學(xué))學(xué)科排名
SCIE(SCI)期刊DRUGS IN R&D(20 21 REV HIST)影響因子
SCIE(SCI)期刊DRUGS IN R&D(DRUGS R&D)總引頻次@(藥理學(xué)與藥學(xué))學(xué)科排名
SCIE(SCI)期刊DRUGS IN R&D(20 21 REV HIST)即時(shí)影響因子
SCIE(SCI)期刊DRUGS IN R&D(DRUGS R&D)即時(shí)影響因子@(藥理學(xué)與藥學(xué))學(xué)科排名
SCIE(SCI)期刊DRUGS IN R&D(20 21 REV HIST)五年累積影響因子
SCIE(SCI)期刊DRUGS IN R&D(DRUGS R&D)五年累積影響因子@(藥理學(xué)與藥學(xué))學(xué)科排名
作者: 痛恨 時(shí)間: 2025-3-21 23:41 作者: GRAVE 時(shí)間: 2025-3-22 03:11 作者: 無(wú)法解釋 時(shí)間: 2025-3-22 05:59
Submitted on: 29 September 2014.
Revised on: 07 December 2014.
Accepted on: 04 January 2015.
___________________DRUGS IN R&D---SPRINGER INT PUBL AG作者: macabre 時(shí)間: 2025-3-22 12:02
Submitted on: 31 May 2024.
Revised on: 04 August 2024.
Accepted on: 03 September 2024.
___________________DRUGS IN R&D---SPRINGER INT PUBL AG作者: habile 時(shí)間: 2025-3-22 16:28 作者: 熱烈的歡迎 時(shí)間: 2025-3-22 19:43
Submitted on: 18 January 2015.
Revised on: 27 February 2015.
Accepted on: 17 April 2015.
___________________DRUGS IN R&D---SPRINGER INT PUBL AG作者: Feckless 時(shí)間: 2025-3-22 22:03 作者: Autobiography 時(shí)間: 2025-3-23 04:16 作者: 把手 時(shí)間: 2025-3-23 05:42 作者: Tincture 時(shí)間: 2025-3-23 10:42
Submitted on: 29 June 1999.
Revised on: 01 August 1999.
Accepted on: 25 September 1999.
___________________DRUGS IN R&D---SPRINGER INT PUBL AG作者: 槍支 時(shí)間: 2025-3-23 13:56
Submitted on: 09 December 1999.
Revised on: 23 February 2000.
Accepted on: 19 March 2000.
___________________DRUGS IN R&D---SPRINGER INT PUBL AG作者: FRONT 時(shí)間: 2025-3-23 18:23 作者: overwrought 時(shí)間: 2025-3-24 00:53
Submitted on: 28 January 2024.
Revised on: 30 March 2024.
Accepted on: 25 April 2024.
___________________DRUGS IN R&D---SPRINGER INT PUBL AG作者: BOOR 時(shí)間: 2025-3-24 05:18
Submitted on: 27 April 2004.
Revised on: 03 August 2004.
Accepted on: 25 August 2004.
___________________DRUGS IN R&D---SPRINGER INT PUBL AG作者: debase 時(shí)間: 2025-3-24 10:29
Submitted on: 27 November 2011.
Revised on: 05 February 2012.
Accepted on: 01 April 2012.
___________________DRUGS IN R&D---SPRINGER INT PUBL AG作者: Terrace 時(shí)間: 2025-3-24 11:35
Submitted on: 22 May 2009.
Revised on: 14 July 2009.
Accepted on: 12 September 2009.
___________________DRUGS IN R&D---SPRINGER INT PUBL AG作者: 笨拙的我 時(shí)間: 2025-3-24 16:27
Submitted on: 12 September 2013.
Revised on: 26 November 2013.
Accepted on: 02 January 2014.
___________________DRUGS IN R&D---SPRINGER INT PUBL AG作者: 實(shí)施生效 時(shí)間: 2025-3-24 22:07
Submitted on: 26 December 2018.
Revised on: 05 March 2019.
Accepted on: 04 May 2019.
___________________DRUGS IN R&D---SPRINGER INT PUBL AG作者: gorgeous 時(shí)間: 2025-3-24 23:50 作者: Blood-Vessels 時(shí)間: 2025-3-25 05:35 作者: 新奇 時(shí)間: 2025-3-25 09:27
Submitted on: 29 June 2006.
Revised on: 09 September 2006.
Accepted on: 02 October 2006.
___________________DRUGS IN R&D---SPRINGER INT PUBL AG作者: BLAND 時(shí)間: 2025-3-25 12:16
Submitted on: 25 March 2019.
Revised on: 15 April 2019.
Accepted on: 01 May 2019.
___________________DRUGS IN R&D---SPRINGER INT PUBL AG作者: 高度 時(shí)間: 2025-3-25 16:51
Submitted on: 15 October 2006.
Revised on: 16 December 2006.
Accepted on: 04 January 2007.
___________________DRUGS IN R&D---SPRINGER INT PUBL AG作者: endarterectomy 時(shí)間: 2025-3-25 22:27
Submitted on: 06 May 2022.
Revised on: 20 August 2022.
Accepted on: 22 September 2022.
___________________DRUGS IN R&D---SPRINGER INT PUBL AG作者: ELATE 時(shí)間: 2025-3-26 03:20
Submitted on: 11 October 2004.
Revised on: 27 November 2004.
Accepted on: 15 December 2004.
___________________DRUGS IN R&D---SPRINGER INT PUBL AG作者: Transfusion 時(shí)間: 2025-3-26 06:21 作者: 包裹 時(shí)間: 2025-3-26 12:33 作者: instructive 時(shí)間: 2025-3-26 16:42 作者: Allure 時(shí)間: 2025-3-26 18:24 作者: affinity 時(shí)間: 2025-3-26 22:30
Submitted on: 09 September 2024.
Revised on: 20 November 2024.
Accepted on: 20 December 2024.
___________________DRUGS IN R&D---SPRINGER INT PUBL AG作者: NAUT 時(shí)間: 2025-3-27 04:00
Submitted on: 28 February 2002.
Revised on: 18 April 2002.
Accepted on: 09 June 2002.
___________________DRUGS IN R&D---SPRINGER INT PUBL AG作者: 遵循的規(guī)范 時(shí)間: 2025-3-27 09:21
Submitted on: 05 August 2002.
Revised on: 14 November 2002.
Accepted on: 06 December 2002.
___________________DRUGS IN R&D---SPRINGER INT PUBL AG作者: indicate 時(shí)間: 2025-3-27 10:47
Submitted on: 01 April 2020.
Revised on: 01 July 2020.
Accepted on: 21 August 2020.
___________________DRUGS IN R&D---SPRINGER INT PUBL AG作者: 語(yǔ)言學(xué) 時(shí)間: 2025-3-27 16:45
Submitted on: 09 September 2012.
Revised on: 06 January 2013.
Accepted on: 31 January 2013.
___________________DRUGS IN R&D---SPRINGER INT PUBL AG作者: integrated 時(shí)間: 2025-3-27 19:34
